ZURICH:Britain on Wednesday became the first country to approve AstraZeneca and Oxford University's home-grown UK COVID-19 vaccine, adding an easy-to-manage shot to the arsenal of a nation desperate for pandemic relief.
Even so, scientists - and regulators in Europe, following the Brexit divorce - are sceptical, given confusion over trial results earlier that left experts questioning the robustness of the data.
HOW DOES THE ASTRAZENECA SHOT'S EFFICACY STACK UP TO OTHERS'?
The AstraZeneca/Oxford vaccine's efficacy in preventing symptomatic infections was 70.4%, according to interim data, after 30 of 5,807 people who got the two-dose vaccine developed COVID-19, compared with 101 of 5,829 people who got a placebo.
That compares with the 95% efficacy of the two-shot vaccine from Pfizer/BioNTech, the other vaccine approved in Britain.
While efficacy with any dose after one dose was pegged at 52.7%, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) regulator also said an "exploratory analysis" of trial participants who got one full dose showed efficacy of 73% from 22 days after the first shot.
The UK regulator recommends a booster shot four to 12 weeks after the first dose, because up to 80% efficacy was reached with a three-month interval between shots, an official involved in the MHRA approval said.
"The first dose efficacy gives an indication of protection for a short period between the two doses, the second dose strengthens the immune response and is expected to provide a more durable immune response," the University of Oxford, AstraZeneca's partner, said.
Confusion over efficacy emerged after interim late-stage trial results announced in late November when AstraZeneca acknowledged that people in its clinical trial accidentally got different doses.
Those who received a half dose of the vaccine, followed by a full dose, were shown to have 90% protection, the company said initially, while two full doses offered only 62% protection.
Now, however, the MHRA said the half-dose regimen's results were not borne out in analysis.
"It's all much more confusing because mistakes have been made, genuinely," one European Medicines Agency (EMA) official told Reuters. "Mistakes that resulted in clinical data that was much more complex to interpret than Moderna's and Pfizer's. And on top of that the efficacy is lower."
WHAT ARE THE OTHER DIFFERENCES?
Technology, price and storage.
The AstraZeneca shot is a "viral vector vaccine", where a specially engineered virus that normally causes chimpanzees to get the common cold delivers genetic instructions to human cells to make the spike protein jutting out from the new coronavirus's surface.
The Pfizer/BioNTech and Moderna vaccines use a new technology which packs messenger RNA (mRNA) inside tiny fat droplets to instruct cells to make the spike protein.
AstraZeneca pledged the vaccine would cost just a few dollars per dose and be sold without making a profit, whereas Pfizer's vaccine costs $18.40-$19.50 per dose.
A separate mRNA vaccine from Moderna, approved in the United States, costs up to $37.
The AstraZeneca shot does not require deep freezing at minus 70 degrees like the mRNA vaccine from Pfizer and its German partner, BioNTech, and has already been produced by the millions of doses.
It can be kept in a standard refrigerator for six months.
It is also cheaper to make, bringing hope to developing countries largely left out of the early vaccine haul.
NOW THAT THE UK HAS APPROVED THE VACCINE, WILL OTHER GOVERNMENTS FOLLOW?
When Britain signed off on Pfizer/BioNTech's vaccine in early December, that pressured regulators elsewhere, and the United States and Europe followed in short order.
Moderna's similar mRNA vaccine has also received U.S. approval.
Britain's move now to back AstraZeneca's shot prioritises getting as many people inoculated quickly, before all the answers about efficacy and optimal dosing are in.
Absent safety concerns, British regulators may be making a trade-off between waiting for perfection and making do with what they have.
"A swift emergency approval implies taking the risks of a lower (or) shorter efficacy than may be reached with mRNA vaccines," said Claire-Anne Siegrist, vaccinology and immunology head at Geneva's University Hospitals.
While an EMA official said this week the shot is unlikely to be approved before the end of January, a top German vaccine official said on Wednesday he still expected a "quick decision" by Europe since its rolling review process is well advanced.
The EU drug watchdog is carrying out a review for a conditional market approval, rather than the UK's speedier emergency use approval.
India's drug regulator is also discussing emergency approval of the AstraZeneca vaccine, being made in partnership with the Serum Institute of India.
WHO WILL GET WHICH VACCINE?
England's National Health Service will not give people a choice of vaccine.
But with several now available, countries need to decide who should get which vaccine, as some people may prefer the shots with higher efficacy.
Experts said the differences between the efficacy rates are significant, prompting tough choices.
"In countries where both the mRNA and the AstraZeneca vaccines would be available, whom do you decide to give the less effective vaccine?" Siegrist said.
Thomas Mertens, head of STIKO, Germany's expert panel on vaccine use, told Reuters that his group plans to address this issue "in the near future" as it hopes to tailor a strategy that makes the biggest impact with limited supplies.
Some experts, however, said that choice may be a luxury countries cannot afford.
"At this juncture, we don't have vaccine in sufficient quantities to reach all those who need it," said Thomas Klimkait, a University of Basel professor and researcher who is working on a Swiss SARS-CoV-2 vaccine project.
"I would say at this moment that every vaccine with relatively good efficacy - that means, at least 60 or 70% - should be put to use, when it has an appropriate safety profile."
Reuters
Thu Dec 31 2020
![Explainer: How does AstraZeneca's vaccine compare with Pfizer-BioNTech? Explainer: How does AstraZeneca's vaccine compare with Pfizer-BioNTech?](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2020-12/81608700270_vaccineAstraZeneca.jpg)
The AstraZeneca/Oxford vaccine's efficacy in preventing symptomatic infections was 70.4%, according to interim data. - REUTERS
![HRD Corp tarik semula surat tuntutan terhadap The Edge - Sim HRD Corp tarik semula surat tuntutan terhadap The Edge - Sim](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81720587505_tbStevenSim.jpg)
HRD Corp tarik semula surat tuntutan terhadap The Edge - Sim
HRD Corp menarik semula surat tuntutan yang diserahkan kepada The Edge berhubung pemberitaan mengenai laporan PAC membabitkan agensi tersebut.
![Khaled Nordin sedia beri kerjasama jika dipanggil PAC berhubung LTAT Khaled Nordin sedia beri kerjasama jika dipanggil PAC berhubung LTAT](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/71720858652_tbKhaledNordin.jpg)
Khaled Nordin sedia beri kerjasama jika dipanggil PAC berhubung LTAT
Menteri Pertahanan bersedia memberikan kerjasama sekiranya dipanggil PAC bagi prosiding LTAT yang akan datang.
Ikuti siaran langsung istiadat pertabalan Sultan Ibrahim sebagai YDPA ke-17
Tanggal 20 Julai 2024 bakal terlakar dalam lipatan sejarah Malaysia dengan pertabalan Sultan Ibrahim sebagai Yang di-Pertuan Agong Ke-17 dalam istiadat gilang-gemilang di Istana Negara. Ikuti siaran langsung istiadat bersejarah ini di saluran 501, Live TV dan platform media sosial Astro AWANI.
"Asah kapak tajam beliung,
Tebang mari kayu berduri,
Tuanku umpama kemuncak payung,
Patik di bawah berteduh diri." - DBP
#AgongKita
"Asah kapak tajam beliung,
Tebang mari kayu berduri,
Tuanku umpama kemuncak payung,
Patik di bawah berteduh diri." - DBP
#AgongKita
"Kenapa sebut nama Arau, Arau tak perlukan mereka..," - YB Arau
YB Arau kemuka 'point of order' berikutan ada yang menyebut namanya.
#SisiTVParlimen
#SisiTVParlimen
Saya baca tadi dalam Bahasa Melayu bukan Bahasa Arab - Dr Dzulkefly
"Saya sangat terkilan setelah berhempas pulas saya memberikan faham kepada Arau, rupa-rupanya tak faham," kata Menteri Kesihatan, Datuk Seri Dr Dzulkefly Ahmad.
#SisiTVParlimen
#SisiTVParlimen
![Gejala Islamofobia perlu ditangani secara tuntas, berkesan - PM Anwar Gejala Islamofobia perlu ditangani secara tuntas, berkesan - PM Anwar](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/71721198691_AnwarIbrahim.jpg)
Gejala Islamofobia perlu ditangani secara tuntas, berkesan - PM Anwar
Gejala Islamofobia perlu ditangani secara tuntas dan berkesan dengan melibatkan usaha pelbagai pihak.
AWANI Ringkas: Jangan cemas tembakan meriam pada Jumaat dan Sabtu
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
![Pelakon tumbuk teman wanita: Kertas siasatan diserah ke TPR Pelakon tumbuk teman wanita: Kertas siasatan diserah ke TPR](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/41721197285_Pelakontumbuktema.jpg)
Pelakon tumbuk teman wanita: Kertas siasatan diserah ke TPR
Kertas siasatan kes pelakon tumbuk teman wanitanya dalam kejadian di Ara Damansara, di sini telah dirujuk ke Timbalan Pendakwa Raya (TPR).
Elektrik terputus, banjir jejaskan 165,000 penduduk Toronto
Hujan lebat di Toronto, Kanada pada Selasa menyebabkan lebih 165,000 pengguna terputus bekalan elektrik, lapor Toronto Hydro.
Banjir juga menyebabkan beberapa kenderaan di bandar itu terkandas di jalan yang ditenggelami air berhampiran Jambatan Dundas.
Banjir juga menyebabkan beberapa kenderaan di bandar itu terkandas di jalan yang ditenggelami air berhampiran Jambatan Dundas.
23 terbunuh, 13 cedera dalam kemalangan bas di Peru
Sekurang-kurangnya 23 orang terbunuh dan 13 cedera di Peru pada Selasa selepas sebuah bas terbalik ketika dalam perjalanan melalui kawasan pergunungan.
Agensi berita Andina melaporkan Ketua Bahagian Perlindungan Lebuh Raya, Jhonny Rolando Valderrama memberitahu bas itu terbabas dari lebuh raya di wilayah Ayacucho andean peru pada waktu senja lalu terbalik dan terjunam ke bawah cerun kira-kira 200 meter.
Agensi berita Andina melaporkan Ketua Bahagian Perlindungan Lebuh Raya, Jhonny Rolando Valderrama memberitahu bas itu terbabas dari lebuh raya di wilayah Ayacucho andean peru pada waktu senja lalu terbalik dan terjunam ke bawah cerun kira-kira 200 meter.
![‘Kes darah beku, serangan jantung tiada kaitan dengan vaksin AstraZeneca’ ‘Kes darah beku, serangan jantung tiada kaitan dengan vaksin AstraZeneca’](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-03/71647054545_DatukDrNoorHisham.jpg)
‘Kes darah beku, serangan jantung tiada kaitan dengan vaksin AstraZeneca’
Golongan berisiko tinggi adalah individu yang mempunyai sejarah pembekuan darah dan mereka tidak dibenarkan menerima vaksin jenis AZ.
![KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-05/51714998751_Dzulkefly.jpg)
KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat
KKM akan mengeluarkan kenyataan berhubung isu penarikan balik vaksin COVID-19 keluaran AstraZeneca dalam masa terdekat.
![Berita antarabangsa pilihan sepanjang hari ini Berita antarabangsa pilihan sepanjang hari ini](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-03/71709993909_TBBERITAx.jpg)
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
![AstraZeneca tarik balik vaksin COVID-19 di seluruh dunia, berbulan selepas sedar ada kesan sampingan AstraZeneca tarik balik vaksin COVID-19 di seluruh dunia, berbulan selepas sedar ada kesan sampingan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-09/51632498837_TBCOVIDVACCINE.jpg)
AstraZeneca tarik balik vaksin COVID-19 di seluruh dunia, berbulan selepas sedar ada kesan sampingan
Vaksin itu tidak lagi boleh digunakan di EU selepas syarikat itu secara sukarela menarik balik "kebenaran pemasarannya."
![KKM beri jaminan dedah data AEFI vaksin COVID-19 - Dr Dzulkefly KKM beri jaminan dedah data AEFI vaksin COVID-19 - Dr Dzulkefly](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-05/51714998751_Dzulkefly.jpg)
KKM beri jaminan dedah data AEFI vaksin COVID-19 - Dr Dzulkefly
KKM memberi jaminan akan mendedahkan semua data berhubung kesan sampingan susulan imunisasi (AEFI) yang berpunca daripada vaksin COVID-19 pada satu waktu yang akan ditetapkan.
![Tiada kesan sampingan daripada vaksin COVID-19 AstraZeneca di Indonesia - Suruhanjaya Tiada kesan sampingan daripada vaksin COVID-19 AstraZeneca di Indonesia - Suruhanjaya](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-09/51632498837_TBCOVIDVACCINE.jpg)
Tiada kesan sampingan daripada vaksin COVID-19 AstraZeneca di Indonesia - Suruhanjaya
Suruhanjaya Nasional untuk Kajian dan Pencegahan Peristiwa Mudarat Berikutan Imunisasi dan BPOM melakukan pemantauan bagi membuat rumusan.
![Kesan sampingan vaksin: KKM akan dapatkan penjelasan AstraZeneca Kesan sampingan vaksin: KKM akan dapatkan penjelasan AstraZeneca](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-05/81714645375_AstraZeneca.jpg)
Kesan sampingan vaksin: KKM akan dapatkan penjelasan AstraZeneca
Kementerian Kesihatan (KKM) akan mendapatkan penjelasan daripada firma farmaseutikal AstraZeneca berhubung kesan sampingan vaksin COVID-19 seperti yang dilaporkan media antarabangsa baru-baru ini.
![AstraZeneca berjaya batalkan saman 12 individu berhubung isu suntikan vaksin COVID-19 AstraZeneca berjaya batalkan saman 12 individu berhubung isu suntikan vaksin COVID-19](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2023-07/71690377692_gaveltukulmahkam.jpg)
AstraZeneca berjaya batalkan saman 12 individu berhubung isu suntikan vaksin COVID-19
Hakim Mahkamah Tinggi Dr Suzana Muhamad Said membenarkan permohonan Astrazeneca untuk membatalkan saman itu selepas mendengar hujahan kedua-dua pihak.
![AstraZeneca rintis inisiatif kesaksamaan akses dalam perkhidmatan kesihatan AstraZeneca rintis inisiatif kesaksamaan akses dalam perkhidmatan kesihatan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2023-10/71697864703_mySihatPal.jpg)
AstraZeneca rintis inisiatif kesaksamaan akses dalam perkhidmatan kesihatan
Portal mySihatPal menutup jurang akses kepada penyelesaian penjagaan kesihatan.
![AstraZeneca tumpu kepada kepada penyakit jarang jumpa, teruskan pelaburan tempatan AstraZeneca tumpu kepada kepada penyakit jarang jumpa, teruskan pelaburan tempatan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-09/71632796213_AstraZenecasthera.jpg)
AstraZeneca tumpu kepada kepada penyakit jarang jumpa, teruskan pelaburan tempatan
AstraZeneca berhasrat menjadi pengupaya penyelesaian yang bekerjasama dalam aspek berbeza kepada pesakit.